Fluoxetine: Clinical Trials

55 trials of Fluoxetine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 8 recruiting, 3 unknown, 3 withdrawn. 55 Phase 2, 9 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 255Completed 37, Recruiting 8, Unknown 3, Withdrawn 3, Terminated 2, Not yet recruiting 1, Suspended 1
Phase 19Completed 4, Recruiting 4, Unknown 1
Phase 35Completed 3, Unknown 2

Follow Fluoxetine: new trials by email Literature Review of Fluoxetine trials Research Report on Fluoxetine

Trials (filtered) newest first · largest first

All 55 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features
Fluoxetine, Placebo - Refractory Constipation, Somatic Symptom Disorder (DSM-5)
Phase 2Not yet recruitingZhifeng Zhao, PhD1942026-09-012026-09-02
Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV
Metformin, Placebo, Fluoxetine - Depression, Hiv
Phase 2WithdrawnUniversity of Minnesota2026-07-012026-07-10
Dapagliflozin in Depression
Fluoxetine, Dapagliflozin - Depression
Phase 1 / Phase 2RecruitingTanta University602025-11-012025-11-25
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety
Fluoxetine (drug), Placebo - Hepatobiliary Malignancy, Fluoxetine
Phase 2RecruitingFirst Affiliated Hospital of Wenzhou Medical University2402025-10-012026-03-24
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
Psilocybin and Psilocyn, Placebo, Psychotherapy-assisted session - Depressive Disorder
Phase 1 / Phase 2RecruitingFederal University of Latin American Integration242024-09-052026-03-27
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg - Depressive Disorder
Phase 2CompletedTanta University752023-06-062026-10-30
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Fluoxetine, Sertraline, Vortioxetine - Depression, Sequestra
Phase 1 / Phase 2RecruitingFirst Affiliated Hospital of Chongqing Medical University5202023-02-202026-01-27
Study of Dextromethorphan in OCD and Related Disorders
Fluoxetine, Dextromethorphan - Obsessive-Compulsive Disorder, Illness Anxiety Disorder
Phase 2RecruitingStanford University602022-01-202026-05-20
TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic
Transcranial Direct Current Stimulation, Placebo-simulation of transcranial direct current stimulation, Fluoxetine Tablets - Major Depressive Disorder
Phase 2 / Phase 3UnknownEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez1722021-10-012021-06-04
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™) - COVID-19
Phase 2RecruitingUniversity of Oxford38002021-09-302026-02-19
Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal Trauma
Fluoxetine, Calcium - Musculoskeletal Injury
Phase 2CompletedUniversity of Florida552021-09-012026-05-14
Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection
Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment
Phase 2 / Phase 3UnknownANRS, Emerging Infectious Diseases6002021-04-122023-01-31
Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania
Fluoxetine 20 MG Oral Tablet - Acute Stroke, Stroke, Ischemic
Phase 2CompletedMassachusetts General Hospital342019-11-262022-05-25
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Fluoxetine - immediate treatment, Fluoxetine - delayed treatment - Obsessive-Compulsive Disorder
Phase 1 / Phase 2RecruitingYale University1002019-10-142026-09-22
Poststroke Depression in Hemorrhagic Stroke
Fluoxetine, Placebo - Stroke Hemorrhagic, Depression
Phase 2CompletedUniversity of Washington82019-03-012025-08-06
Fluoxetine Opens Window to Improve Motor Recovery After Stroke
Fluoxetine Hydrochloride, Placebo, Exercise Program - Stroke, Cerebrovascular Accident
Phase 2CompletedUniversity Health Network, Toronto522019-01-012022-11-04
Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
Fluoxetine, Placebo - Epilepsy, SUDEP
Phase 2CompletedRup Kamal Sainju302017-02-162020-05-04
RCT of a Neuroplasticity Agent and CI Therapy for Severe Arm Paresis After Stroke
Fluoxetine, Placebo, eCMIT - Severe Stroke With Affected Arm Motor Function
Phase 2WithdrawnUniversity of Alabama at Birmingham2016-11-012015-01-12
Fluoxetine for Visual Recovery After Ischemic Stroke
Fluoxetine, Placebo - Acute Stroke, Visual Field Loss
Phase 2TerminatedBogachan Sahin172016-05-012021-10-13
Hierarchical Treatment Based on Somatization Symptom Checklist
Deanxit, Prozac, coronary artery disease treatment - Syndrome X
Phase 1 / Phase 2UnknownRenJi Hospital2002015-12-012020-03-04

Showing 20 of 55. Sign in to see all of them.

Conditions studied

Depression (14)  ·  Depressive Disorder, Major (9)  ·  Stroke (6)  ·  Depressive Disorder (4)  ·  Anxiety Disorders (3)  ·  COVID-19 (3)  ·  Ischemic Stroke (3)  ·  Obsessive-Compulsive Disorder (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Autistic Disorder (2)  ·  Dysthymic Disorder (2)  ·  Fatigue (2)  ·  Pulmonary Arterial Hypertension (2)  ·  Adenocarcinoma of Lung (1)  ·  Aggression (1)

Sponsors

New York State Psychiatric Institute (3)  ·  University of Minnesota (3)  ·  University of Pittsburgh (3)  ·  Massachusetts General Hospital (2)  ·  Tanta University (2)  ·  University Hospital, Toulouse (2)  ·  University of Texas Southwestern Medical Center (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bogachan Sahin (1)  ·  Brigham and Women's Hospital (1)  ·  Centro Medico Teknon (1)  ·  Chengdu University of Traditional Chinese Medicine (1)  ·  El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez (1)

Countries

United States (33)  ·  China (4)  ·  Mexico (3)  ·  Brazil (2)  ·  Egypt (2)  ·  France (2)  ·  Burkina Faso (1)  ·  Canada (1)  ·  Guinea (1)  ·  Iran (1)  ·  Laos (1)  ·  Nepal (1)  ·  Pakistan (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Meredith Gunlicks-Stoessel, PhD (2)  ·  Akbar Fotouhi, MD, PhD (1)  ·  Al Rivera, MD (1)  ·  Albert Nadal, MD (1)  ·  Andrew W Goddard, MD (1)  ·  Arash Etemadi, MD, PhD (1)  ·  Arthur J. Barsky, MD (1)  ·  Behtash Saeidi, MD (1)  ·  Bradley MacIntosh, PhD (1)  ·  Brian Fallon, MD (1)  ·  Carl Gommoll, MS (1)  ·  Christopher Pittenger, MD, PhD (1)  ·  Courtney Pollock, PhD (1)  ·  Daniel S Pine, M.D. (1)

Results publications

PMID 10990547, PMID 11063978, PMID 11723286, PMID 12244081, PMID 12949224, PMID 14677403, PMID 15147306, PMID 15351385, PMID 15365580, PMID 15987799, PMID 16002441, PMID 16794566, PMID 17414235, PMID 17591596, PMID 18053120, PMID 18061147, PMID 18314433, PMID 19182688, PMID 19223438, PMID 19321268, PMID 19332318, PMID 19403329, PMID 19414708, PMID 19485586, PMID 19671217, PMID 19730273, PMID 19730274, PMID 19853048, PMID 19858762, PMID 19968380, PMID 20008943, PMID 20478877, PMID 20576364, PMID 20633386, PMID 20673556, PMID 21068312, PMID 21167786, PMID 21192150, PMID 21208583, PMID 21216670, PMID 21334569, PMID 21383263, PMID 21515198, PMID 21631313, PMID 21784297, PMID 21890211, PMID 22024002, PMID 22032743, PMID 22189047, PMID 22193671

NIH funding

K24MH121571 (1), R01AA013370 (1), R01AA015173 (1), R01DA006234 (1), R01DA019142 (1), R01MH063011 (1), R01MH066984 (1), R01MH071688 (1), R01MH116038 (1), U01MH061835 (1), U01MH093582 (1), U10CA031946 (1), U10MH066750 (1), U10MH066762 (1), U10MH066769 (1)